Ainos Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 20.00 K
- Company Age 1 Year 4 Months
- Last Filing with ROC 31 Mar 2024
About Ainos Pharmaceuticals
Ainos Pharmaceuticals Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 September 2023 (One year and four months 30 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Packaging Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 20.00 K , as per Ministry of Corporate Affairs (MCA) records.
Manish Doshi and Vandana Doshi serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U21002MH2023PTC410647
-
Company No.
410647
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
16 Sep 2023
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Ainos Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manish Doshi
|
Director | 16-Sep-2023 | Current |
|
Vandana Doshi
|
Director | 16-Sep-2023 | Current |
Financial Performance of Ainos Pharmaceuticals.
Enhance accessibility to Ainos Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ainos Pharmaceuticals?
Unlock access to Ainos Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Umedica Laboratories Private LimitedManish Doshi and Vandana Doshi are mutual person
-
Kmi Business Technologies Private LimitedManish Doshi is a mutual person
-
Amoli Investment Services Private LimitedManish Doshi and Vandana Doshi are mutual person
-
Amoli Properties Private Limited
Manish Doshi and Vandana Doshi are mutual person
-
Umedica Properties Private Limited
Manish Doshi and Vandana Doshi are mutual person
-
Sweta Pharma Pvt LtdManish Doshi and Vandana Doshi are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ainos Pharmaceuticals?
Unlock and access historical data on people associated with Ainos Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ainos Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ainos Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.